EyePoint Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About EyePoint Inc
EyePoint Inc focuses on developing and commercializing innovative therapeutics for serious retinal diseases. It develops therapies for serious retinal diseases to provide durable treatments that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained release product candidate for retinal diseases with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
/ 
Frequently asked questions
To buy EyePoint Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for EyePoint Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for EyePoint Inc is EYPT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
EyePoint Inc has its primary listing on NASDAQ. You can trade EyePoint Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, EyePoint Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include EyePoint Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like EyePoint Inc.